[ad_1] As more doctors prescribe Pfizer’s powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug.
[ad_1] At a psychiatric hospital in Michigan, Dr. Cara Poland’s patients were handed a sheet of paper to find follow-up care. The hospital had entered local ZIP codes on a
[ad_1] By JEFF GOLDSMITH and ERIC LARSEN It has been a rough year so far for digital health. After an astonishing $45 billion poured into new digital health companies in
[ad_1] Cerebral, the digital mental health ‘unicorn’, said on Saturday May 7, it was under investigation by the federal government for “possible violations of the Controlled Substances Act.” The company
[ad_1] Imagine that you are a policymaker and an academic researcher shows you evidence for a new health intervention that will dramatically improve health outcomes. He shows you the study
[ad_1] The Food and Drug Administration’s decision to limit the use of the Johnson & Johnson COVID-19 vaccine won’t have a significant impact on health systems. The FDA scaled back
[ad_1] A bill signed into law by Arizona Gov. Doug Ducey on Friday requires health insurers and the state’s Medicaid plan to pay for so-called “biomarker tests” that are needed
[ad_1] Asked about the effect of an abortion ban on Tennessee women at a Thursday news conference, Republican Gov. Bill Lee, who opposes abortion, pointed to the extension. “It’s important
[ad_1] The 11th Circuit is one of the most conservative federal appeals courts in the country, with seven judges appointed by Republican presidents and four by Democrats. It sets precedent
[ad_1] Doug Lambrecht was among the first of the nearly 1 million Americans to die from COVID-19. His demographic profile – an older white male with chronic health problems –